Sunesis Pharmaceuticals Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Sunesis Pharmaceuticals is a biotechnology company focused on the development and future commercialization of oncology therapies for hematologic and solid tumor cancers. It has built a cancer drug development organization dedicated to advancing translational and clinical science to bring new treatments to patients. Its lead program centers on an oral, non-covalent BTK inhibitor, vecabrutinib (SNS-062), pursued as a potential therapy for ibrutinib-resistant chronic lymphocytic leukemia.